欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
AT/H/0683/002
药品名称
Flexbumin
活性成分
albumin human 250.0 g/l
剂型
Solution for infusion
上市许可持有人
Baxalta Innovations GmbH, Austria
参考成员国 - 产品名称
Austria (AT)
Flexbumin 250 g/l - Infusionslösung
互认成员国 - 产品名称
Italy (IT)
Greece (GR)
Cyprus (CY)
许可日期
2008/04/05
最近更新日期
2024/12/23
药物ATC编码
B05AA01 albumin
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
PubAR
|
AT_H_0683_PAR_Flexbumin solution for infusion
Date of last change:2025/01/02
Final SPC
|
Common English SmPC_ Flexbumin_ 250 gl_ solution for infusion_ EU_ _en__ Feb_2023_2
Date of last change:2024/09/06
Final Labelling
|
common_lab_flexbumin_200gl_IS comments_clean
Date of last change:2024/09/06
Final Labelling
|
common_lab_flexbumin_250gl_IS comments_clean
Date of last change:2024/09/06
Final PL
|
common_pl_flexbumin200glsolutionforinfusionclean
Date of last change:2024/09/06
Final PL
|
common_pl_flexbumin250glsolutionforinfusionclean
Date of last change:2024/09/06
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase